首页 | 本学科首页   官方微博 | 高级检索  
检索        

中国玫瑰痤疮临床特征分析和诊断标准再探讨
引用本文:汪犇,赵志祥,简丹,施为,刘芳芬,刘慧,余斌,夏建新,杨洁,吴琳,鞠强,李吉,谢红付.中国玫瑰痤疮临床特征分析和诊断标准再探讨[J].中华皮肤科杂志,2020,53(9):675-679.
作者姓名:汪犇  赵志祥  简丹  施为  刘芳芬  刘慧  余斌  夏建新  杨洁  吴琳  鞠强  李吉  谢红付
作者单位:1中南大学湘雅医院皮肤科国家老年疾病临床医学研究中心(湘雅),长沙410008; 2广西医科大学第一附属医院皮肤科, 南宁530021;3福建医科大学附属第二医院皮肤科,福建泉州362000;4吉林大学第二医院皮肤科,长春130041;5华北理工大学附属医院皮肤科,河北唐山063000;6北京大学深圳医院皮肤科,深圳518036;7上海交通大学附属仁济医院皮肤科201112
基金项目:国家自然科学基金(81773351、81974480)
摘    要:【摘要】 目的 在分析玫瑰痤疮临床特征的基础上,提出中国玫瑰痤疮诊断标准并验证其敏感性和特异性。方法 纳入2017年12月至2018年7月于中南大学湘雅医院皮肤科门诊初诊的3 350例玫瑰痤疮患者,分析患者表型及临床特征,提出改良版中国玫瑰痤疮诊断标准。全国28个中心对该标准进行临床验证,纳入2 269例玫瑰痤疮和2 408例其他面部皮肤病患者,与2017版美国国家玫瑰痤疮专家委员会(NRSEC)制订的国际诊断标准比较,评估其敏感性和特异性。结果 3 350例玫瑰痤疮患者均存在面中部持续性红斑(100%)。在1 861例主要表现为面颊部红斑的患者中,1 850例(99.4%)在红斑之前或同时出现阵发性潮红;在1 489例主要表现为鼻或口周部红斑的患者中,仅52例(3.5%)发生阵发性潮红; 342例有肥大增生的患者均在肥大增生改变之前发生持续性红斑。基于以上临床特征提出,面颊部可周期性加重的伴有阵发性潮红的持续性红斑,可诊断为玫瑰痤疮;对于表现为鼻、口周部持续性红斑的患者,需合并至少1项选择性表型(阵发性潮红、毛细血管扩张、丘疹脓疱、肥大增生改变或眼部症状)才可诊断为玫瑰痤疮。全国多中心临床验证结果显示,改良版中国玫瑰痤疮诊断标准敏感性为99.6%,接近国际标准100%,特异性为91.9%,而国际标准为73.3%。结论 改良版中国玫瑰痤疮诊断标准具有良好的敏感性和特异性,也更有利于增生肥大型玫瑰痤疮的早期诊断。

关 键 词:红斑痤疮  诊断  红斑  潮红  面中部持续性红斑  
收稿时间:2020-04-17

Analysis of clinical features of rosacea and rediscussion of a Chinese diagnostic criterion for rosacea
Wang Ben,Zhao Zhixiang,Jian Dan,Shi Wei,Liu Fangfen,Liu Hui,Yu Bin,Xia Jianxin,Yang Jie,Wu Lin,Ju Qiang,Li Ji,Xie Hongfu.Analysis of clinical features of rosacea and rediscussion of a Chinese diagnostic criterion for rosacea[J].Chinese Journal of Dermatology,2020,53(9):675-679.
Authors:Wang Ben  Zhao Zhixiang  Jian Dan  Shi Wei  Liu Fangfen  Liu Hui  Yu Bin  Xia Jianxin  Yang Jie  Wu Lin  Ju Qiang  Li Ji  Xie Hongfu
Abstract:【Abstract】 Objective To propose a Chinese diagnostic criterion for rosacea on the basis of clinical feature analysis of rosacea, and to assess its sensitivity and specificity. Methods A total of 3 350 Chinese patients with newly diagnosed rosacea were collected from Department of Dermatology, Xiangya Hospital, Central South University between December 2017 and July 2018, their phenotypes and clinical features were retrospectively analyzed, and a Chinese modified diagnostic criterion for rosacea was put forward. A national multi-center clinical observational trial, which included 2 269 patients with rosacea and 2 408 patients with other facial skin diseases from 28 centers, was conducted to verify this diagnostic criterion. Then, the sensitivity and specificity of the modified diagnostic criterion were evaluated by comparing with the 2017 standard classification of rosacea developed by the National Rosacea Society Expert Committee (NRSEC). Results Fixed centrofacial erythema occurred in 3 350 (100%) patients with rosacea. Flushing occurred before or simultaneously with fixed erythema in 1 850 (99.4%) of the 1 861 patients with erythema on the cheeks; among the 1 489 patients with erythema on the nose or perioral area, only 52(3.5%) had flushing; all the 342 patients presenting with phymatous changes had fixed erythema before phymatous changes. Based on the above clinical findings, it was proposed that patients with periodically aggravated fixed erythema on the cheeks accompanied with flushing could be diagnosed with rosacea; patients with fixed erythema on the nose and perioral area accompanied with at least one of selective phenotypes (flushing, telangiectasia, papules and pustules, phymatous changes, or ocular manifestations) could be diagnosed with rosacea. The national multi-center clinical observational trial revealed that the sensitivity of the Chinese modified diagnostic criterion for rosacea was 99.6%, which was close to the sensitivity (100%) of the NRSEC standard, and its specificity was 91.9%, higher than the specificity (73.3%) of the NRSEC standard. Conclusion The Chinese modified diagnostic criterion for rosacea has good sensitivity and specificity, and can facilitate the early diagnosis of phymatous rosacea.
Keywords:Rosacea  Diagnosis  Erythema  Flushing  Fixed centrofacial erythema  
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号